Literature DB >> 31957521

Effects of Sodium Reduction on Energy, Metabolism, Weight, Thirst, and Urine Volume: Results From the DASH (Dietary Approaches to Stop Hypertension)-Sodium Trial.

Stephen P Juraschek1, Edgar R Miller2, Alexander R Chang3, Cheryl A M Anderson4, John E Hall5, Lawrence J Appel2.   

Abstract

Two recent studies challenged traditional paradigms of mammalian sodium physiology, suggesting that sodium reduction might cause weight gain by altering metabolism. This new theory has important implications for population-wide dietary recommendations. However, these observations have not been confirmed. In the DASH (Dietary Approaches to Stop Hypertension)-Sodium trial, 412 adults with systolic blood pressure of 120 to 159 mm Hg and diastolic blood pressure of 80 to 95 mm Hg not taking antihypertensive medications were randomly assigned to the DASH diet or a control diet (parallel design). On their assigned diet, participants randomly consumed each of the 3 sodium levels for 4 weeks (crossover design). Participants were provided all meals but could drink noncaloric beverages (eg, water) freely. Throughout the trial, energy intake was adjusted to maintain weight constant. The 3 sodium levels (at 2100 kcal/day) were: low (1150 mg of Na/day), medium (2300 mg of Na/day), and high (3450 mg of Na/day). Energy intake, weight, self-reported thirst, and 24-hour urine volume were assessed after each period. Participants were 57% women and 57% black; mean age was 48 years [SD, 10]). Among those assigned the control, mean weight increased slightly with higher sodium but not among those assigned DASH. Energy intake did not vary across sodium levels in either diet (P-trends ≥0.36). Higher sodium resulted in more thirst (P-trends <0.001 on both diets) and higher urine volume (suggesting higher fluid intake) during the control diet (P-trend=0.007). Reducing sodium did not increase energy requirements to maintain stable weights but did decrease thirst and urine volume (control diet only), findings consistent with the traditional understanding of mammalian sodium physiology. Clinical Trial Registration URL: http://www.clinicaltrials.gov. Unique identifier: NCT00000608.

Entities:  

Keywords:  adult; blood pressure; metabolism; sodium; thirst

Mesh:

Substances:

Year:  2020        PMID: 31957521      PMCID: PMC7278848          DOI: 10.1161/HYPERTENSIONAHA.119.13932

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  17 in total

1.  Nutrition and health. The issue is not food, nor nutrients, so much as processing.

Authors:  Carlos A Monteiro
Journal:  Public Health Nutr       Date:  2009-05       Impact factor: 4.022

2.  The DASH Diet, Sodium Intake and Blood Pressure Trial (DASH-sodium): rationale and design. DASH-Sodium Collaborative Research Group.

Authors:  L P Svetkey; F M Sacks; E Obarzanek; W M Vollmer; L J Appel; P H Lin; N M Karanja; D W Harsha; G A Bray; M Aickin; M A Proschan; M M Windhauser; J F Swain; P B McCarron; D G Rhodes; R L Laws
Journal:  J Am Diet Assoc       Date:  1999-08

3.  Worldwide prevalence of hypertension exceeds 1.3 billion.

Authors:  Michael J Bloch
Journal:  J Am Soc Hypertens       Date:  2016-09-19

4.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group.

Authors:  F M Sacks; L P Svetkey; W M Vollmer; L J Appel; G A Bray; D Harsha; E Obarzanek; P R Conlin; E R Miller; D G Simons-Morton; N Karanja; P H Lin
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

5.  Effect of salt intake on renal excretion of water in humans.

Authors:  F J He; N D Markandu; G A Sagnella; G A MacGregor
Journal:  Hypertension       Date:  2001-09       Impact factor: 10.190

6.  Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study.

Authors:  Andrew Mente; Martin O'Donnell; Sumathy Rangarajan; Matthew McQueen; Gilles Dagenais; Andreas Wielgosz; Scott Lear; Shelly Tse Lap Ah; Li Wei; Rafael Diaz; Alvaro Avezum; Patricio Lopez-Jaramillo; Fernando Lanas; Prem Mony; Andrzej Szuba; Romaina Iqbal; Rita Yusuf; Noushin Mohammadifard; Rasha Khatib; Khalid Yusoff; Noorhassim Ismail; Sadi Gulec; Annika Rosengren; Afzalhussein Yusufali; Lanthe Kruger; Lungiswa Primrose Tsolekile; Jephat Chifamba; Antonio Dans; Khalid F Alhabib; Karen Yeates; Koon Teo; Salim Yusuf
Journal:  Lancet       Date:  2018-08-09       Impact factor: 79.321

7.  Salt and water: not so simple.

Authors:  Mark L Zeidel
Journal:  J Clin Invest       Date:  2017-04-17       Impact factor: 14.808

8.  Urine osmolality estimated using urine urea nitrogen, sodium and creatinine can effectively predict response to tolvaptan in decompensated heart failure patients.

Authors:  Teruhiko Imamura; Koichiro Kinugawa; Shun Minatsuki; Hironori Muraoka; Naoko Kato; Toshiro Inaba; Hisataka Maki; Taro Shiga; Masaru Hatano; Atsushi Yao; Shunei Kyo; Issei Komuro
Journal:  Circ J       Date:  2013-01-12       Impact factor: 2.993

Review 9.  Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials.

Authors:  Feng J He; Jiafu Li; Graham A Macgregor
Journal:  BMJ       Date:  2013-04-03

10.  Time Course of Change in Blood Pressure From Sodium Reduction and the DASH Diet.

Authors:  Stephen P Juraschek; Mark Woodward; Frank M Sacks; Vincent J Carey; Edgar R Miller; Lawrence J Appel
Journal:  Hypertension       Date:  2017-11       Impact factor: 10.190

View more
  8 in total

1.  Sex and race differences in urinary Tumor Necrosis Factor-α (TNF-α) levels: Secondary analysis of the DASH-sodium trial.

Authors:  Elizabeth D Drugge; Khalid Farhan; Hong Zhao; Rozalia Abramov; Lesley A Graham; Nancy Stambler; Shoujin Hao; Nicholas R Ferreri
Journal:  J Hum Hypertens       Date:  2022-08-25       Impact factor: 2.877

2.  Home-delivered meals as an adjuvant to improve volume overload and clinical outcomes in hemodialysis.

Authors:  Luis M Perez; Annabel Biruete; Kenneth R Wilund
Journal:  Clin Kidney J       Date:  2022-04-19

3.  High dietary salt intake increases urinary NGAL excretion and creatinine clearance in healthy young adults.

Authors:  Alex M Barnett; Matthew C Babcock; Joseph C Watso; Kamila U Migdal; Orlando M Gutiérrez; William B Farquhar; Austin T Robinson
Journal:  Am J Physiol Renal Physiol       Date:  2022-02-14

4.  Association of Usual Sodium Intake with Obesity Among US Children and Adolescents, NHANES 2009-2016.

Authors:  Lixia Zhao; Cynthia L Ogden; Quanhe Yang; Sandra L Jackson; Catherine M Loria; Deborah A Galuska; Jennifer L Wiltz; Robert Merritt; Mary E Cogswell
Journal:  Obesity (Silver Spring)       Date:  2021-02-02       Impact factor: 9.298

5.  Urine Metabolites Associated with the Dietary Approaches to Stop Hypertension (DASH) Diet: Results from the DASH-Sodium Trial.

Authors:  Hyunju Kim; Alice H Lichtenstein; Kari E Wong; Lawrence J Appel; Josef Coresh; Casey M Rebholz
Journal:  Mol Nutr Food Res       Date:  2020-12-28       Impact factor: 6.575

6.  Serum aldosterone and urine electrolytes dynamics in response to DASH diet intervention - An inpatient mechanistic study.

Authors:  Dana Bielopolski; Adam Qureshi; Ohad S Bentur; Andrea Ronning; Jonathan N Tobin; Rhonda Kost
Journal:  J Clin Transl Sci       Date:  2022-04-25

7.  High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension.

Authors:  Giacomo Rossitto; Giuseppe Maiolino; Silvia Lerco; Giulio Ceolotto; Gavin Blackburn; Sheon Mary; Giorgia Antonelli; Chiara Berton; Valeria Bisogni; Maurizio Cesari; Teresa Maria Seccia; Livia Lenzini; Alessio Pinato; Augusto Montezano; Rhian M Touyz; Mark C Petrie; Ronan Daly; Paul Welsh; Mario Plebani; Gian Paolo Rossi; Christian Delles
Journal:  Cardiovasc Res       Date:  2021-04-23       Impact factor: 10.787

Review 8.  Arterial hypertension - Clinical trials update 2021.

Authors:  Hussam Al Ghorani; Felix Götzinger; Michael Böhm; Felix Mahfoud
Journal:  Nutr Metab Cardiovasc Dis       Date:  2021-09-16       Impact factor: 4.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.